Cystatin C: New Clinical Chemistry Parameter Available For DRG:HYBRiD-XL
DRG is glad to announce the next release of a clinical chemistry assay. Cystatin C is the latest released parameter for DRG:HYBRiD-XL and is ready to be purchased!
Martina Werner, Member of the European Parliament Visits Marburg-Biedenkopf District and DRG International
Martina Werner, Member of the European Parliament, visited the district of Marburg-Biedenkopf on Friday, January 23, 2016.
DRG:HYBRID-XL and Vitamin D 25-OH Assay Used in Major Study in Poland Linking Vitamin D Deficiency to Patients with Myocardial Infarction!
The DRG:HYBRiD.XL has been used in Poland along with the DRG Vitamin D 25-OH (HYE5334) assay to determine valuable findings in the cardiovascular realm.
Visit DRG at EuroMed 2013!
Please mark your calendars and make sure to visit the DRG booth on May 19-22, 2013 at the Euromed Show in Milan, Italy.
DRG International Featured as Spotlight Company Of 2012 AACC
DRG International was proud to be a participant at the 2012 American Association of Clinical Chemistry (AACC) – the Largest Clinical Lab Exposition in the World – held on July 17-19 2012.
Hospitalar 2011, May 24-27 in Sao Paulo, Brazil
The DRG® product line met with enthusiasm, as DRG® again participated in the Hospitalar Exhibition 2011 in Sao Paolo, Brazil, May 24 to May 27.
DRG International, Inc. Associates Awarded Certification of Completion in Dangerous Goods Transportation
DRG International, Inc. is proud to announce that several of its associates were recently awarded the Certification of Completion by the Unz&CO Multi-Modal Dangerous Goods Transportation Seminar.
New Website of DRG International, Inc.
DRG International, Inc. (USA) is glad to introduce the new website which has an optimized structure for faster loading and compatibility with the latest Internet software.
National Scientific Conference
DRG will be represented at the 32nd National Scientific Conference of the Association of Medical Technologists of Thailand, 7-9 May 2008
Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.
Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.